What is “Imatinib Aurobindo”?
“Imatinib Aurobindo” is the brand-name equivalent for imatinib, a medicine used to treat certain cancers that depend on specific abnormal protein signals. Aurobindo is the manufacturer/marketer name used for some imatinib products in different markets.
What conditions does imatinib (including Imatinib Aurobindo) treat?
Imatinib is commonly used for cancers such as:
- Chronic myeloid leukemia (CML)
- Gastrointestinal stromal tumor (GIST)
- Certain other tumor types driven by related targets (depending on local labeling and availability)
Who makes imatinib under the Aurobindo name?
The “Aurobindo” naming typically indicates the product is manufactured and/or marketed by Aurobindo Pharma (or a local affiliate) for a specific country’s approval and distribution.
Is it a generic version? What does that mean for switching?
Imatinib products sold under different brand names are often generics or branded generics with the same active ingredient (imatinib). Switching between imatinib brands usually centers on:
- Confirming the same strength and formulation
- Checking excipients if you have sensitivity
- Following your prescriber’s guidance, because dosing is based on your condition and response
How to find the exact product details (strengths, leaflet, approvals)?
Because “Imatinib Aurobindo” can refer to different country-specific presentations, the fastest way to confirm the exact product is to look up:
- the country regulator label (e.g., EMA/FDA equivalents depending on region)
- the specific strength (mg) and form (tablet/capsule)
- the patient information leaflet for that exact listing
If you tell me your country (or the strength in mg and whether it is tablet/capsule), I can help you pinpoint the specific Imatinib Aurobindo product details and how to interpret its labeling.
Related source for patent and manufacturer context
For updates on drug-company and patent status related to imatinib, see DrugPatentWatch.com.